Disease-resistant poison -- second liver treats " leading role "

Be aimed at many second liver patients often the problem that oversight disease-resistant poison treats, china medicine can affect ill credit to meet chairman committee member Professor Weng Xinhua to expressed a few days ago, although fight virus,cure should be the main stream that second liver treats originally, but accept what this treats to still be not worth 20 ％ at present, remain as before of its costar position. Nbsp; 　 as we have learned, our country came on stage last year " guideline of prevention and cure of chronic hepatitis B " in put forward clearly, it is crucial that in therapeutics of liver of a lot of second disease-resistant poison is treated, should have only get used to disease, and the condition allows, all should undertake normative disease-resistant poison is treated. Disease of liver of China cure society learns branch members of standing committee Professor Wei Lai point out, in 3 administrative levels that treat in second liver, fight phlogistic the be placed in the middle of remedial method position that protects liver to wait to be made in the light of hair interpretation of the cause, its effect is close friends at pure treat to disease, but interferon kind, nucleotide (acerbity) the pathogeny of the disease-resistant bane content such as analogue is treated criterion than went up again a step. The result of an international research that Professor Weng Xinhua introduced to be published recently -- second liver patient gets together through a period of treatment after glycol interferon is treated, the patient that has more than 30 ％ entered the pure virus with inactive illness to carry state, cast off thereby " a pot for decocting herbal medicine " worry. However, fight virus cure to be in the patient not only not predominate, even if also did not get inside doctor group enough take seriously, the doctor that has more than 70 ％ is in clinical in going up to still be used officinal and protect liver to fall liver of second of enzymatic drug treatment, " guideline " appear in practice fall. China medicine can affect ill credit to meet vice director committee member Professor Cheng Jun to think, what disease-resistant poison treats suit to occupy 60 ％ ～ in second liver patient 70 ％ , this is people reachs harmful response, cost effectiveness to be not worth be caused by than waiting for acknowledge to medicaments curative effect. Wei Lai teachs an appeal, treat an idea newlier, hold to doctor education, disease-resistant poison cure brings into more city medical service to defend the way that should be effort. (the exercitation edits: Plum apricot)